- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.05. | Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey | ||
| 27.05. | Biogen investigated by Italian regulator over multiple sclerosis 'market abuse' claims | ||
| 27.05. | FDA delays ruling on AstraZeneca's breast cancer drug after negative adcomm vote | ||
| 26.05. | Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg | ||
| 26.05. | SK bioscience links up with Colombia to enable local production of varicella vaccine | ||
| 26.05. | After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod | ||
| 26.05. | Acadia boosts 'More To Parkinson's' campaign with Ryan Reynolds, Parkinson's voices | ||
| 22.05. | Novartis, AbbVie plan summer layoffs on opposite coasts | ||
| 22.05. | AbbVie, GSK race up patient reputation leaderboard in the UK | ||
| 22.05. | AbbVie plots 85 summer layoffs tied to Allergan unit in California | ||
| 22.05. | Tyra creates awareness day with patient advocates to shine light on a rare cancer | ||
| 22.05. | Europe's CHMP gives thumbs up to AstraZeneca's breast cancer drug after thumbs down from FDA adcomm | ||
| 22.05. | AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway | ||
| 22.05. | Fierce Pharma Asia-Merck-Kelun ADC's triple wins; Tools in China licensing deals; Takeda's $885M antitrust loss | ||
| 21.05. | ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer | ||
| 21.05. | Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme | ||
| 21.05. | Inside agency view: Ogilvy Health on AI's 'light speed,' nano influencers and the rise of Ria | ||
| 21.05. | Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume | ||
| 21.05. | Gilead pledges 400K AmBiosome doses to fight visceral leishmaniasis in expanded WHO collab | ||
| 21.05. | With Voxzogo under pressure, BioMarin touts trial win in label expansion bid | ||
| 20.05. | BMS taps Anthropic's Claude for enterprise-wide AI adoption to speed R&D, global workflows | ||
| 20.05. | CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues | ||
| 20.05. | Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus | ||
| 20.05. | Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M | ||
| 20.05. | Tarsus taps John Cena for its latest Demodex blepharitis campaign |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.